Consumers and health professionals are advised that Beijing Tong Ren Tang Australia in consultation with the TGA is recalling Batch 16080020 and Batch 4080015 of Bronchi-cough Pills (qiguanyan kesou tanchuanwan; AUST L 144659) due to contamination with substances that pose an unacceptable risk to health.
TGA testing has found that both currently available batches of the product are contaminated with low levels of amygdalin. One batch (16080020) is also contaminated with very low levels of aristolochic acid. Both amygdalin and aristolochic acid are included in Schedule 10 to the Poisons Standard, which lists substances considered to pose an unacceptable risk to health.
There is no established safe exposure level to aristolochic acids, which have been linked to kidney problems and urinary tract cancers.
Information for consumers
If you or someone you provide care for takes Bronchi-cough Pills, please be alert to this issue and discontinue use immediately. The product should not be consumed.
If you have any Bronchi-cough Pills, the remaining product can be returned to the place of purchase for a refund.
If you have any questions or concerns about this issue, talk to your health professional or contact 1300 287 828.
Information for health professionals
Please be aware of the above issue and advise patients regarding alternative treatment options if they seek advice.
If you have any questions or concerns about this issue, contact 1300 287 828.
The TGA cannot give advice about an individual's medical condition. You are strongly encouraged to talk with a health professional if you are concerned about a possible adverse event associated with a medicine or vaccine.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.